HETERO LABS LTD III FDA Approval ANDA 203540

ANDA 203540

HETERO LABS LTD III

FDA Drug Application

Application #203540

Application Sponsors

ANDA 203540HETERO LABS LTD III

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET;ORAL400MG0RALTEGRAVIRRALTEGRAVIR

FDA Submissions

UNKNOWN; ORIG1TA2014-09-30

Submissions Property Types

ORIG1Null19

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203540
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"RALTEGRAVIR","activeIngredients":"RALTEGRAVIR","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/30\/2014","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-09-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.